Announcements

Job offersmore »



Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (ON): Aphria inks wholesale supply deal with Scientus Pharma

Aphria, through its subsidiary Pure Natures Wellness, entered into a major wholesale supply agreement with HydRx Farms. Under the terms of the Agreement, Aphria is committing to supply over 25,000 fully grown medical cannabis plants over the next 12 months to Scientus Pharma. The first delivery, under the agreement will occur in the middle of Aphria’s second quarter of 2018. Aphria expects to generate over $1.2 million of revenue from the wholesale supply agreement in each full quarter of
shipments, with gross margins consistent with previously executed wholesale agreements.



Scientus Pharma, a vertically-integrated biopharmaceutical company, is raising the bar of cannabinoid products from medical-grade to pharmaceutical-grade. Leveraging its proprietary, patent-pending formulation and processing technologies, Scientus Pharma is committed to leading the medical cannabis market towards pharmaceutical standards in manufacturing, formulations and dosing.

“Scientus Pharma shares our vision for providing high-quality products to medical cannabis patients, which is enabled by our 509-step Seed-to Sale quality assurance program,” said Vic Neufeld, Chief Executive Officer of Aphria. “Through this agreement, Scientus Pharma will get access to clean and safe cannabis, which is necessary in the biopharmaceutical cannabis industry. In return, Aphria will benefit from guaranteed product distribution advancing Aphria’s growth strategy.”

“Scientus Pharm intends to leverage this key raw material supply contract to help it lead the evolution of cannabinoid products from medical-grade to pharmaceutical-grade,” said Trevor Folk, Chief Executive Officer of Scientus Pharma. “Our proprietary extraction technology platform has solved the resin consistency issue that has here-to-for prevented that scientific advancement, and it is the foundation for Scientus Pharma’s pipeline of novel products.”

For more information:
Aphria Inc.
Vic Neufeld
President & CEO
1-844-427-4742
aphria.com

Scientus Pharma
209 Dundas St. E
PO Box 31 Whitby
Whitby, ON L1N 5R7
T: +1 844 493.7922
info@scientuspharma.com
scientuspharma.com

Publication date: 7/6/2017

 


 

Other news in this sector:

4/23/2018 Another cannabis investment for Scotts Miracle-Gro
4/23/2018 Canada: Researcher warns cannabis bubble might burst
4/20/2018 US (NM): Cannabis provider unveils 8.7 million sq.ft. facility
4/20/2018 The great cannabis switcheroo
4/19/2018 Canada: MPX to acquire MMJ producer Canveda
4/18/2018 US (NV): Marapharm's Las Vegas sites get green light to flip the switch
4/18/2018 CAN (ON): MedReleaf completes 1 million sq.ft. greenhouse acquisition
4/17/2018 CAN (BC): BC Tweed adds licensed growing space
4/17/2018 New cannabis strain to be named after Meghan Markle
4/16/2018 US: Trump, Gardner strike deal on legalized marijuana
4/13/2018 Malta: Australian firm to build 4,000 m2 MMJ facility
4/12/2018 US: Former Republican Speaker of the House joins cannabis firm
4/12/2018 Canada: Québec orders tons of cannabis from six growers
4/12/2018 US: Fluence shines light on state-of-the-art cannabis greenhouse
4/11/2018 US (CA): Cannabis company receives $1M insurance payout following fire
4/10/2018 Canada: Canopy to help LiveWell develop cannabis greenhouses
4/9/2018 Italian firm files patent for solar powered cannabis and cryptocurrency farm
4/6/2018 Canada: Marijuana millionaires riding legalization wave
4/6/2018 CAN (ON): First harvest from Aphria expansion expected end of April
4/5/2018 LED Grower's Guide for Cannabis